Proficiency of nerve conduction using standard methods and reference values (cl. NPhys Trial 4)
dc.contributor.author | Litchy, William J. | en_US |
dc.contributor.author | Albers, James W. | en_US |
dc.contributor.author | Wolfe, James | en_US |
dc.contributor.author | Bolton, Charles F. | en_US |
dc.contributor.author | Walsh, Nancy | en_US |
dc.contributor.author | Klein, Christopher J. | en_US |
dc.contributor.author | Zafft, Andrew J. | en_US |
dc.contributor.author | Russell, James W. | en_US |
dc.contributor.author | Zwirlein, Melanie | en_US |
dc.contributor.author | Overland, Carol J. | en_US |
dc.contributor.author | Davies, Jenny L. | en_US |
dc.contributor.author | Carter, Rickey E. | en_US |
dc.contributor.author | Dyck, Peter J. | en_US |
dc.date.accessioned | 2014-12-09T16:53:57Z | |
dc.date.available | WITHHELD_13_MONTHS | en_US |
dc.date.available | 2014-12-09T16:53:57Z | |
dc.date.issued | 2014-12 | en_US |
dc.identifier.citation | Litchy, William J.; Albers, James W.; Wolfe, James; Bolton, Charles F.; Walsh, Nancy; Klein, Christopher J.; Zafft, Andrew J.; Russell, James W.; Zwirlein, Melanie; Overland, Carol J.; Davies, Jenny L.; Carter, Rickey E.; Dyck, Peter J. (2014). "Proficiency of nerve conduction using standard methods and reference values (cl. NPhys Trial 4)." Muscle & Nerve 50(6): 900-908. | en_US |
dc.identifier.issn | 0148-639X | en_US |
dc.identifier.issn | 1097-4598 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/109629 | |
dc.description.abstract | Introduction The Cl. NPhys Trial 3 showed that attributes of nerve conduction (NC) were without significant intraobserver differences, although there were significant interobserver differences. Methods : Trial 4 tested whether use of written instructions and pretrial agreement on techniques and use of standard reference values, diagnostic percentile values, or broader categorization of abnormality could reduce significant interobserver disagreement and improve agreement among clinical neurophysiologists. Results : The Trial 4 modifications markedly decreased, but did not eliminate, significant interobserver differences of measured attributes of NC. Use of standard reference values and defined percentile values of abnormality decreased interobserver disagreement and improved agreement of judgment of abnormality among evaluators. Therefore, the same clinical neurophysiologist should perform repeat NCs of therapeutic trial patients. Conclusions : Differences in interobserver judgment of abnormality decrease with use of common standard reference values and a defined percentile level of abnormality, providing a rationale for their use in therapeutic trials and medical practice. Muscle Nerve 50: 900–908, 2014 | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.publisher | Elsevier | en_US |
dc.subject.other | Multicenter Trial | en_US |
dc.subject.other | Nerve Conduction Accuracy | en_US |
dc.subject.other | Neuropathy Impairment Score | en_US |
dc.subject.other | Reference Values | en_US |
dc.subject.other | Nerve Conduction Proficiency | en_US |
dc.title | Proficiency of nerve conduction using standard methods and reference values (cl. NPhys Trial 4) | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/109629/1/mus24243.pdf | |
dc.identifier.doi | 10.1002/mus.24243 | en_US |
dc.identifier.source | Muscle & Nerve | en_US |
dc.identifier.citedreference | Kimura J. Nerve conduction and needle electromyograpy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Vol. 1. Philadelphia: Elsevier; 2005. p 899 – 970. | en_US |
dc.identifier.citedreference | Dyck PJ, Albers JW, Wolfe J, Bolton CF, Walsh N, Klein CJ, et al. A trial of proficiency of nerve conduction: greater standardization still needed. Muscle Nerve 2013; 48: 369 – 374. | en_US |
dc.identifier.citedreference | Ziegler D, Low PA, Litchy WJ, Boulton AJ, Vinik AI, Freeman R, et al. Efficacy and safety of antioxidant treatment with alpha‐lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 Trial. Diabetes Care 2011; 34: 2054 – 2060. | en_US |
dc.identifier.citedreference | Ziegler D, Ametov A, Barinov A, Dyck PJ, Gurieva I, Low PA, et al. Oral treatment with alpha‐lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 2006; 29: 2365 – 2370. | en_US |
dc.identifier.citedreference | Apfel SC, Schwartz S, Adornato BT, Freeman R, Biton V, Rendell M, et al. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy. A randomized controlled trial. JAMA 2000; 284: 2215 – 2221. | en_US |
dc.identifier.citedreference | Dyck PJ, O'Brien PC, Oviatt KF, Dinapoli RP, Daube JR, Bartleson JD, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol 1982; 11: 136 – 141. | en_US |
dc.identifier.citedreference | Schifitto G, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, et al. Long‐term treatment with recombinant nerve growth factor for HIV‐associated sensory neuropathy. Neurology 2001; 57: 1313 – 1316. | en_US |
dc.identifier.citedreference | Thompson PD, Thomas PK. Clinical patterns of peripheral neuropathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier; 2005. p 1137 – 1162. | en_US |
dc.identifier.citedreference | Chaudhry V, Cornblath DR, Mellitis ED, Avila O, Freimer ML, Glass JD, et al. Inter‐ and intra‐examiner reliability of nerve conduction measurements in normal subjects. Ann Neurol 1991; 30: 841 – 843. | en_US |
dc.identifier.citedreference | Dyck PJ, Argyros B, Russell JW, Gahnstrom L, Naleppa S, Albers JW, et al. Multicenter trial of the proficiency of smart quantitative sensation tests. Muscle Nerve 2013 Aug 8. [Epub ahead of print]. PMID: 23929701. DOI: 10.1002/mus.23982. | en_US |
dc.identifier.citedreference | Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, et al. "Unequivocally abnormal" vs. "usual" signs and symptoms for proficient diagnosis of diabetic polyneuropathy Cl vs. N Phys Trial. Arch Neurol 2012; 69: 1609 – 1614. | en_US |
dc.identifier.citedreference | Dyck PJ, Litchy WJ, Lehman KA, Hokanson JL, Low PA, O'Brien PC. Variables influencing neuropathic endpoints: the Rochester Diabetic Neuropathy Study of healthy subjects (RDNS‐HS). Neurology 1995; 45: 1115 – 1121. | en_US |
dc.identifier.citedreference | Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Dyck PJB, et al. Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys Trial. Muscle Nerve 2010; 42: 157 – 164. | en_US |
dc.identifier.citedreference | Suanprasert N, Berk JL, Benson MD, Dyck PJB, Klein CJ, Gollob JA, et al. Toward representative quantitation of neuropathy signs and tests in transthyretin amyloidosis. 2014 (in preparation). | en_US |
dc.identifier.citedreference | Grant IA, Benstead TJ. Differential diagnosis of polyneuropathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Vol. 1. Philadelphia: Elsevier; 2005. p 1163 – 1180. | en_US |
dc.identifier.citedreference | Smith BE, Windebank AJ, Dyck PJ. Nonmalignant inflammatory sensory polyganglionopathy. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy, 4th ed. Philadelphia: Elsevier Saunders; 2005. p 2309 – 2320. | en_US |
dc.identifier.citedreference | Berk JL, Suhr OB, Obici L, Sekijima Y, Zeldenrust SR, Yamashita T, et al. Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial. JAMA 2013; 310: 2658 – 2667. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.